Jingwei Duan

Dr. Jingwei Duan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2023 in Medical Physics
Verified
Journal Article
Open access
JDJingwei Duan
Jingwei Duan
MBMark E. Bernard
Mark E. Bernard
JCJames R. Castle
James R. Castle
XFXue Feng
Xue Feng
CWChi Wang
Chi Wang
QCQuan Chen
Quan Chen
Background: Contouring error is one of the top failure modes in radiation treatment. Multiple efforts have been made to develop tools to automatically detect segmentation errors. Deep learning‐based auto‐segmentation (DLAS) has been used as a baseline for flagging manual segmentation errors, but those efforts are limited to using only one or two contour comparison metrics.Purpose: The purpose of this research is to develop an improved contouring quality assurance system to identify and flag manual contouring errors.Methods and materials: DLAS contours were used as a reference to compare with manually segmented contours. A total of 27 geometric agreement metrics were determined from the comparisons between the two segmentation approaches. Feature selection was performed to optimize the training of a machine learning classification model to identify potential contouring errors. A public dataset with 339 cases was used to train and test the classifier. Four independent classifiers were trained using five‐fold cross validation, and the predictions from each classifier were ensembled using soft voting. The trained model was validated on a held‐out testing dataset. An additional independent clinical dataset with 60 cases was used to test the generalizability of the model. Model predictions were reviewed by an expert to confirm or reject the findings.Results: The proposed machine learning multiple features (ML‐MF) approach outperformed traditional nonmachine‐learning‐based approaches that are based on only one or two geometric agreement metrics. The machine learning model achieved recall (precision) values of 0.842 (0.899), 0.762 (0.762), 0.727 (0.842), and 0.773 (0.773) for Brainstem, Parotid_L, Parotid_R, and mandible contours, respectively compared to 0.526 (0.909), 0.619 (0.765), 0.682 (0.882), 0.773 (0.568) for an approach based solely on Dice similarity coefficient values. In the external validation dataset, 66.7, 93.3, 94.1, and 58.8% of flagged cases were confirmed to have contouring errors by an expert for Brainstem, Parotid_L, Parotid_R, and mandible contours, respectively.Conclusions: The proposed ML‐MF approach, which includes multiple geometric agreement metrics to flag manual contouring errors, demonstrated superior performance in comparison to traditional methods. This method is easy to implement in clinical practice and can help to reduce the significant time and labor costs associated with manual segmentation and review.

3 March 2025 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
JDJingwei Duan
Jingwei Duan
JPJoel A. Pogue
Joel A. Pogue
DSDennis N. Stanley
Dennis N. Stanley
SSSui Shen
Sui Shen
NVNatalie N. Viscariello
Natalie N. Viscariello
JHJoseph Harms
Joseph Harms
Purpose/objectives: Recent technological advancements have increased efficiency for clinical deliverability of online‐adaptive‐radiotherapy (oART). Previous cone‐beam‐computed‐tomography (CBCT) generations lacked the ability to provide reliable Hounsfield‐units (HU), thus requiring oART workflows to rely on synthetic‐CT (sCT) images derived through deformable‐image‐registration (DIR) between the planning CT (pCT) and the daily CBCT. These sCTs are prone to errors stemming from DIR, potentially contributing to dosimetric errors. This study aims to evaluate the capability of direct dose calculation using a novel CBCT platform, HyperSight (Varian‐Medical‐Systems), as an alternative for sCT.Methods/materials: To validate the HyperSight iterative CBCT (HS‐iCBCT) HU accuracy, 125 kV and 140 kV HS‐iCBCT calibration curves were benchmarked against a pCT calibration curve. To determine the clinical impact of HS‐iCBCT compared to sCT, daily adaptive sessions from 47 oART fractions from 10 patients were analyzed. For these patients, HS‐iCBCT was acquired for daily adaption, and sCT was generated as part of the standard adaptive workflow. After daily adaption, dose was recalculated directly using the HS‐iCBCT, and the HS‐iCBCT and sCT dose distributions were compared by γ‐index and dose‐volume‐histogram (DVH) analysis.Results: The mean HU differences of pCT minus HS‐iCBCT (140/125 kV) were −40.97/−57.79, 9.86/21.74, and 87.22/158.20 for lung, water, and bone. In the patient cohort, the median gamma passing rates between HS‐iCBCT and sCT‐based dose calculations for 3%/2 mm and 1%/1 mm were 99.57 and 96.45% with 10% threshold, and 99.92% and 86.15% with 80% threshold. Dosimetric deviations in high dose regions were concentrated in areas with larger deformation, that is, surface change and variable bladder/bowel filling. The median (min‐max) D98%/V100% absolute deviations were 0.3(0.0–1.6)/0.0(0.0–13.7) and 0.4(0.0–1.4)/0.5(0.0–17.5) for CTVs and PTVs.Conclusions: The HS‐iCBCT platform with iterative reconstruction provides dose calculation comparable to sCT for pelvis and breast patients. However, acceptable, yet noticeable, dose discrepancies between HS‐iCBCT and sCT exist, particularly in high‐dose regions. Further investigations are needed to benchmark these methods against ground truth measurements.

17 February 2025 in Advances in Radiation Oncology
Verified
Journal Article
Open access
JDJingwei Duan
Jingwei Duan
JHJoseph Harms
Joseph Harms
DBDrexell H. Boggs
Drexell H. Boggs
AKAdam J. Kole
Adam J. Kole
RPRichard A. Popple
Richard A. Popple
JPJoel A. Pogue
Joel A. Pogue
Online adaptive radiation therapy (oART) has shown the ability to diminish interfraction variations. However, oART is a time- and labor-intensive process, and the optimal adaptation frequency remains to be determined for lung cancer oART. The purpose of this study was to quantify and assess dosimetric benefits associated with various adaptive frequencies in patients with lung cancer receiving oART. This study included 8 patients with lung cancer receiving oART treated on the Ethos platform in 30 or 33 fractions (n = 7 /1). For a total of 243 fractions, daily contours on cone-beam computed tomography (CT) and adaptive/nonadaptive plans on synthetic CT scan were used to simulate 4 different adaptation frequencies: none, single, weekly, and daily adaptation, resulting in 972 unique dose distributions. Dose-volume-histograms of targets and organs-at-risk (OARs) were compared between adaptation frequencies. Besides Dose-volume-histogram analysis, 3 radiation oncologists reviewed and scored 185 total plans, evenly sampling plans from the various adaptive frequencies. A comprehensive plan scorecard was fine-tuned to correlate with physician reviews and subsequently used for interplan comparison. Compared with no adaptation, daily adaptation improved the median clinical target volume V100% by 0.2% (IQR, 0.0-1.0) and the planning target volume D98% by 0.5% (IQR, -2.2 to 3.83). It also reduced the planning target volume D0.03cc by 2.1% (IQR, 0.7-3.2), the lungs-internal target volume V20 Gy by 2.5% (IQR, 1.0-4.5), the heart Dmean by 0.9 Gy (IQR, 0.4-2.6), and the esophagus Dmean by 1.6 Gy (IQR, 0.3-4.3). Single and weekly adaptation presented fewer benefits in OAR sparing and led to target undercoverage compared with daily adaptation. The PlanScoreCard effectively quantified plan quality, showing a positive monotonic correlation to physician scores (R = 0.57-0.87). It revealed that daily adaptation significantly improved total plan quality for 7 out of 8 patients, with improvements exceeding 5% of the plan score compared with no adaptation. In contrast, weekly and single adaptations led to improvements in only 2 and 1 patients, respectively. Online kilovoltage cone-beam CT scan-guided daily adaptation may lead to dosimetric benefits in both target coverage and OAR sparing in patients with lung cancer. Other adaptation frequencies are effective for some patients but tend to lead to target undercoverage compared with daily adaptation.

10 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
LZLibing Zhu
Libing Zhu
JRJean-Claude M. Rwigema
Jean-Claude M. Rwigema
XFXue Feng
Xue Feng
BABilaal Ansari
Bilaal Ansari
JDJingwei Duan
Jingwei Duan
QCQuan Chen
Quan Chen
Background/Objectives: The accurate delineation of primary tumors (GTVp) and metastatic lymph nodes (GTVn) in head and neck (HN) cancers is essential for effective radiation treatment planning, yet remains a challenging and laborious task. This study aims to develop a deep-learning-based auto-segmentation (DLAS) model trained on external datasets with false-positive elimination using clinical diagnosis reports. Methods: The DLAS model was trained on a multi-institutional public dataset with 882 cases. Forty-four institutional cases were randomly selected as the external testing dataset. DLAS-generated GTVp and GTVn were validated against clinical diagnosis reports to identify false-positive and false-negative segmentation errors using two large language models: ChatGPT-4 and Llama-3. False-positive ruling out was conducted by matching the centroids of AI-generated contours with the slice locations or anatomical regions described in the reports. Performance was evaluated using the Dice similarity coefficient (DSC), 95th percentile Hausdorff distance (HD95), and tumor detection precision. Results: ChatGPT-4 outperformed Llama-3 in accurately extracting tumor locations from the diagnostic reports. False-positive contours were identified in 15 out of 44 cases. The DSCmean of the DLAS contours for GTVp and GTVn increased from 0.68 to 0.75 and from 0.69 to 0.75, respectively, after the ruling-out process. Notably, the average HD95 value for GTVn decreased from 18.81 mm to 5.2 mm. Post ruling out, the model achieved 100% precision for GTVp and GTVn when compared with the results of physician-determined contours. Conclusions: The false-positive ruling-out approach based on diagnostic reports effectively enhances the precision of DLAS in the HN region. The model accurately identifies the tumor location and detects all false-negative errors.

12 June 2025 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
LZLibing Zhu
Libing Zhu
NYNathan Y. Yu
Nathan Y. Yu
SASafia K. Ahmed
Safia K. Ahmed
JAJonathan B. Ashman
Jonathan B. Ashman
DTDiego Santos Toesca
Diego Santos Toesca
YRYi Rong
Yi Rong
Purpose: Lattice radiation therapy (LRT) is a form of spatially fractionated radiation therapy that allows increased total dose delivery aiming for improved treatment response without an increase in toxicities, commonly utilized for palliation of bulky tumors. The LRT treatment planning process is complex, while eligible patients often have an urgent need for expedited treatment start. In this study, we aimed to develop a simulation‐free workflow for volumetric modulated arc therapy (VMAT)‐based LRT planning via deep learning‐predicted synthetic CT (sCT) to expedite treatment initiation. Methods: Two deep learning models were initially trained using 3D U‐Net architecture to generate sCT from diagnostic CTs (dCT) of the thoracic and abdomen regions using a training dataset of 50 patients. The models were then tested on an independent dataset of 15 patients using image similarity analysis assessing mean absolute error (MAE) and structural similarity index measure (SSIM) as metrics. VMAT‐based LRT plans were generated based on sCT and recalculated on the planning CT (pCT) for dosimetric accuracy comparison. Differences in dose volume histogram (DVH) metrics between pCT and sCT plans were assessed using the Wilcoxon signed‐rank test. Results: The final sCT prediction model demonstrated high image similarity to pCT, with a MAE and SSIM of 38.93 ± 14.79 Hounsfield Units (HU) and 0.92 ± 0.05 for the thoracic region, and 73.60 ± 22.90 HU and 0.90 ± 0.03 for the abdominal region, respectively. There were no statistically significant differences between sCT and pCT plans in terms of organ‐at‐risk and target volume DVH parameters, including maximum dose (Dmax), mean dose (Dmean), dose delivered to 90% (D90%) and 50% (D50%) of target volume, except for minimum dose (Dmin) and (D10%). Conclusion: With demonstrated high image similarity and adequate dose agreement between sCT and pCT, our study is a proof‐of‐concept for using deep learning predicted sCT for a simulation‐free treatment planning workflow for VMAT‐based LRT.

3 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
LZLibing Zhu
Libing Zhu
NYNathan Y. Yu
Nathan Y. Yu
RTRiley C. Tegtmeier
Riley C. Tegtmeier
JAJonathan B. Ashman
Jonathan B. Ashman
AAAman Anand
Aman Anand
YRYi Rong
Yi Rong
Objectives: Identifying patients’ advantageous radiotherapy modalities prior to CT simulation is challenging. This study aimed to develop a workflow using deep learning (DL)-predicted synthetic CT (sCT) for treatment modality comparison based solely on a diagnostic CT (dCT). Methods: A DL network, U-Net, was trained utilizing 46 thoracic cases from a public database to generate sCT images predicting planning CT (pCT) scans based on the latest dCT, and tested on 15 institutional patients. The sCT accuracy was evaluated against the corresponding pCT and a commercial algorithm deformed CT (MdCT) based on Mean Absolute Error (MAE) and Universal Quality Index (UQI). To determine advantageous treatment modality, clinical dose-volume histogram (DVH) metrics and Normal Tissue Complication Probability (NTCP) differences between proton and photon treatment plans were analyzed on the sCTs via concordance correlation coefficient (CCC). Results: The AI-generated sCTs closely resembled those of the commercial deformation algorithm in the tested cases. The differences in MAE and UQI values between the sCT-vs-pCT and MdCT-vs-pCT were 19.38 HU and 0.06, respectively. The mean absolute NTCP deviation between sCT and pCT was 1.54%, 0.21%, and 2.36% for esophagus perforation, lung pneumonitis, and heart pericarditis, respectively. The CCC between sCT and pCT was 0.90 for DVH metrics and 0.97 for NTCP, indicating moderate agreement for DVH metrics and substantial agreement. Conclusions: Radiation oncologists can potentially utilize this personalized sCT based approach as a clinical support tool to rapidly compare the treatment modality benefit during patient consultation and facilitate in-depth discussion on potential toxicities at a patient-specific level.